Oxford Global, Boston, USA
10 - 11 May 2017
Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. The conference programme will consist of 3 interactive streams convering: - Genome Editing Technologies
- Drug Discovery & Development Applications
- Therapeutic Applications of Genome Editing
Across the two-day event, our expert panel of speakers will offer a comprehensive view at critical advances in genome editing research. We will also be hosting key biotech solution providers, giving attendees the chance to hear about the very latest state-of-the-art technologies. The event will be co-located with our Inaugural Advances in Transgenic Technologies Congress. Day one features a whole session dedicated to exploring the opportunities and challenges of genome editing technologies. The afternoon will be split into interactive workshops covering key areas such as target identification and therapeutic applications. On day two the technology session will move more toward the development of delivery solutions, software and bioinformatic aspects of genome editing and key regulatory issues. The morning workshops will address genome editing approaches to accelerate drug discovery.
|